Skip to main content
Clinical Trials/NCT02186067
NCT02186067
Completed
Not Applicable

Developing an Integrated System Approach for the Management of Hypertension: A Pilot Study

Aga Khan University1 site in 1 country118 target enrollmentFebruary 2014
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Aga Khan University
Enrollment
118
Locations
1
Primary Endpoint
At least an absolute 20% point greater proportion of participants in the intervention group achieving blood pressure targets ( SBP <140 mmHg and DBP < 90mmHg)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Hypertension has become a public health concern worldwide due to its significant contribution to the global health burden and its role as a prominent risk factor for the development of a number of chronic diseases such as Cardiovascular diseases (CVD), the leading cause of mortality in Pakistan and Worldwide. According to WHO, about 7.5 million deaths worldwide is attributable to hypertension i.e. about 12.8% of the total of all deaths. This accounts for 57 million disability adjusted life years (DALYS) or 3.7% of total DALYS.

Studies suggest that hypertension is among the top five most common presenting complaints to private general practice clinics. Therefore, primary care physicians/Family physicians are the first line service providers and; thus it is important to manage hypertensive patients early, through lifestyle and treatment interventions that may prevent the complications such as development of CVDs etc.

Detailed Description

To the best of authors' knowledge limited evidence is available from Pakistan on management of hypertension through an integrated approach. Therefore, the aim of the trial is to develop a health delivery system that effectively manages hypertension at primary care level. Hypothesis: The development of an integrated management approach will be effective in managing hypertension at all levels among hypertensive patients.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
March 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Waris Qidwai

Professor and Chairman Department of Family Medicine

Aga Khan University

Eligibility Criteria

Inclusion Criteria

  • Individuals aged 40 years or over visiting the selected IMS centre with known hypertension or with consistently elevated BP on two separate visits (mean of last two of three measurements of systolic pressure ≥140 mm Hg or mean diastolic pressure ≥90 mm Hg) or already receiving treatment will be eligible for inclusion in the study.

Exclusion Criteria

  • Those patients who require intensive care unit or coronary care unit admissions, or are diagnosed to have cognitive impairment, are agitated due to severe pain, non-resident of Karachi, or having language barrier will be excluded from the study.
  • A screening form will be designed for the collection of the above mentioned information. The rationale of excluding all the participants with above mentioned condition is that the participants having these health concerns will either not be able to respond to our questionnaire or their presence may confound our results.

Outcomes

Primary Outcomes

At least an absolute 20% point greater proportion of participants in the intervention group achieving blood pressure targets ( SBP <140 mmHg and DBP < 90mmHg)

Time Frame: 6 months

Secondary Outcomes

  • Adherence to life style modification(6 months)
  • Adherence by physicians to hypertension management guidelines(6 months)
  • Cost-Effectiveness(6 months)
  • Patient Satisfaction(6 months)

Study Sites (1)

Loading locations...

Similar Trials